Well review 30 actual colonoscopy claims from your practice and show you exactly where the gaps are.
Key efficacy study: -5.1% body weight, -35% fat mass, no change in appetite Lead efficacy study Mice (DIO) C57BL/6, 60% kcal-from-fat diet, 20 mg/kg x3/day subcutaneous, 11 days, n=9-10/group Neelakantan et al
Underlying Health Conditions (e.g., Anemia, Fatigue Disorders) Conditions like pernicious anemia, chronic fatigue, fibromyalgia, or malabsorption issues (e.g., IBS, celiac) often require ongoing support
Key Takeaways Morning administration (6-8 AM) on an empty stomach maximizes metabolic benefits and aligns with natural circadian rhythms Consistent daily timing creates stable NNMT enzyme suppression for optimal fat metabolism and energy production Fasted state dosing (30-60 minutes before meals) enhances absorption and bioavailability of 5-Amino-1MQ Cycling protocols (8-12 weeks on, 4-6 weeks off) help maintain receptor sensitivity and prevent tolerance Split dosing strategies may benefit advanced users seeking sustained metabolic support throughout the day Understanding 5-Amino-1MQ and Why Timing Matters 5-Amino-1MQ (5-Amino-1-methylquinolinium) represents a breakthrough in metabolic optimization research
Alternatively, oral supplements can be used alongside occasional injections depending on symptoms and lab results